Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Posted inAcquired Immune Deficiency Syndrome Africa Argentina Baluchistan (Pakistan) Brazil China Colombia Developing Countries Drugs (Pharmaceuticals) Epidemics Generic Brands and Products Gilead Sciences Inc Intellectual Property Inventions and Patents lenacapavir Medicine and Health Prices (Fares, Fees and Rates)

Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries

Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.
Why We’re Still Breathing Dirty Indoor Air
Posted inCarbon Dioxide Centers for Disease Control and Prevention Coronavirus (2019-nCoV) Epidemics Heating, Ventilation and Cooling (HVAC) Hygiene and Cleanliness Occupational Safety and Health Administration Office of Science and Technology Policy SARS (Severe Acute Respiratory Syndrome) Science and Technology Viruses Workplace Environment World Health Organization

Why We’re Still Breathing Dirty Indoor Air

The pandemic and recent wildfires have shown how unhealthy indoor air can be. But scientific and governmental inertia have slowed the necessary remedies.